TrialPanorama/Dataset huggingface dataset:
Please select the eligibility criteria that correspond to the clinical trial below.
Title: The SIM-SOF Trial: A Randomized Trial Comparing Simeprevir-Sofosbuvir Versus Peginterferon/Ribavirin/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype-1a-infected Patients With Cirrhosis
Brief Summary: Randomized trial of Hepatitis C-genotype 1-infected patients with compensated cirrhosis comparing the standard of care (Peginterferon/Ribavirin/Sofosbuvir) versus the off-label combination of simeprevir+ sofosbuvir without Ribavirin.


Options:
A: Inclusion Criteria:

* adult patients, 18-65 years of age;
* chronic hepatitis C, genotype 1.

Exclusion Criteria:

* decompensated liver disease, or impaired liver function;
* presence or history of non-hepatitis C chronic liver disease;
* HBsAg or HIV infection;
* history of cancer within 5 years, other than localized or in situ cancer of the skin.
B: Inclusion criteria:

* Has chronic HCV genotype 1 infection
* Is treatment-experienced
* For the non-cirrhotic population, has had a liver biopsy without evidence of cirrhosis and hepatocellular carcinoma; for the cirrhotic population, has had a liver biopsy with evidence of cirrhosis and without evidence of hepatocellular carcinoma.

Exclusion criteria:

* Has not tolerated previous course peg-IFN and RBV
* Is unlikely to tolerate at least 24 weeks of continuous therapy with Peg-IFN and RBV
* Is co-infected with Human Immunodeficiency Virus (HIV) and/or hepatitis B
* Consumes excessive amounts of alcohol
* Has a history of drug or alcohol abuse
* If female, participant is pregnant or breastfeeding
* Has been in a clinical trail with an investigational drug in the last 30 days
* Has used IFN/Peg-IFN and RBV in the last 3 months
C: Inclusion Criteria:

* chronic hepatitis c,
* cirrhosis biopsy-proven, or via fibrotest,
* CPT score less than 7,
* genotype 1a,
* INR 2.3 or less,
* serum albumin greater than 2.7 gm/dL,
* total bilirubin less than 3 gm/dL,
* platelet count 50,000 per cubic milliliter or more
* GFR \>50 ml/min

Exclusion Criteria:

* non genotype 1a,
* history of CPT class B or C or decompensation or history of same,
* HIV or HBV coinfection,
* prior treatment with boceprevir, telaprevir or any other direct acting antiviral agent,
* uncontrolled psychiatric or cardiopulmonary disorders,
* planning pregnancy or unwilling/unable to practice contraception
D: Inclusion Criteria:

* adult patients, \>=18 years of age;
* chronic hepatitis C, genotype 1;
* treatment-naive.

Exclusion Criteria:

* liver cirrhosis and other forms of liver disease;
* HIV infection;
* hepatocellular cancer;
* cardiac disease.

Answer: C
Please select the eligibility criteria that correspond to the clinical trial below.
Title: N/A
Brief Summary: This study is to compare between oral misoprostol in solution and vaginal dinoprostone in induction of labour in primiparous women with singleton pregnancy as regards efficiency and safety to both mother and fetus.


Options:
A: Inclusion Criteria:

* Primigravida
* \>37 wks

Exclusion Criteria:

* Scarred uterus
* Macrosomia
B: Inclusion Criteria:

* Indication for labour induction
* Term pregnancy with alive fetus
* Bishop score less than six

Exclusion Criteria:

* Age less than 18 years
* Previous uterine scar
* Nonvertex presentation
* Non-reassuring fetal status
* Fetal anomalies
* Fetal growth restriction
* Genital bleeding
* Tumors, malformations and/or ulcers of vulva, perineum or vagina
C: Inclusion Criteria:

* 34 to 42 weeks of gestation
* live singleton
* Bishop score \< or = 6
* reassuring fetal heart beat pattern

Exclusion Criteria:

* nonreassuring fetal heart beat pattern
* parity ovr five
* any contraindication to labor and/or vaginal delivery
* uterine scar
* suspected placental abruption with abnormal FHR pattern
* vaginal bleeding other than "bloody show"
* cervical dilatation of \> or = 4 cm
* uterine contractions \> or = 3 in 10 minutes
* significant maternal cardiac, renal or hepatic disease
* hypersensitivity to misoprostol or prostaglandin analogs
D: Inclusion Criteria:

1. Pregnant Female Patients greater than or equal to 18 years of age
2. Induction of labor for a single live intrauterine pregnancy
3. Greater than or equal to 37 weeks gestational age
4. Cephalic presentation
5. 20 minute reassuring fetal heart rate (reactive nonstress test (NST))
6. Bishop score based on sterile vaginal exam of less than or equal to 6, for which the cervical dilation is less than or equal to 2 cm.
7. Equal to 3 or less uterine contractions over 10 minutes

Exclusion Criteria:

1. Previous uterine scar
2. Contraindication to vaginal delivery
3. Patients with preeclampsia
4. Grand multiparty - greater than or equal to 5 live births or stillbirths
5. Premature rupture of membranes
6. Suspected intrauterine growth restriction
7. Fetal anomalies
8. Contraindication to misoprostol (history of allergy to prostaglandins, glaucoma)

Answer: A
Please select the eligibility criteria that correspond to the clinical trial below.
Title: EmPhAsIS: Empowering Pharmacists in Asthma Management Through Interactive SMS
Brief Summary: Between 8% and 12% of Canadians suffer from asthma. Although there are effective and inexpensive treatments, adherence to asthma treatment is amongst the lowest for all chronic diseases.The purpose of this study is to determine whether enhancing the role of community pharmacists in asthma management using interactive short messaging service (SMS) with asthma patients is a cost-effective model that will improve adherence to inhaled corticosteroid medications compared to usual care.


Options:
A: Inclusion Criteria:

* individuals who fill a (incident or prevalent) prescription for inhaled corticosteroids (either monotherapy or in combination inhaler with long-acting beta-agonists) who have been diagnosed by a doctor as having asthma
* possessing a cell-phone with ability to send/receive text messages
* residing in British Columbia (BC), Canada and planning to reside in BC for the next 12 months
* registered with the medical services plan (MSP, the provincial insure of medically-required services) in the past 12 months, and planning to remain registered for the next 12 months
* designated pharmacy being the main drugstore for patient
* not participating in another interventional study
* consent to participate in the study.

Exclusion Criteria:

* Unable to communicate in English
* Under 14 years of age
B: Inclusion Criteria:

* Received treatment for asthma in the year prior to study entry
* Received at least one respiratory medication at a Kaiser Permanente Northwest (KPNW) or Kaiser Permanente Hawaii (KPH) outpatient pharmacy in the year prior to study entry
* Continuous Kaiser Permanente membership from the year prior to study entry through study entry
* Willing to participate in the study

Exclusion Criteria:

* Excluded from primary analyses if fewer than three months of follow-up
C: Inclusion Criteria:

* Inclusion criteria required that the child have at least one claim with a diagnostic code for asthma or reactive airway disease (International Classification of Diseases (ICD 9) diagnostic code 493.xx) and in the last year period had either1) been hospitalized for asthma
* had at least 2 Emergency Department (ED) visits
* 3-5 ambulatory visits due to asthma
* utilized asthma medications from 2 of the following therapeutic categories: Anticholinergics, cromolyn, sympathomimetics, steroid inhalants, methylxanthines, leukotriene inhibitors, or corticosteroids.

Exclusion Criteria:

* currently participating in another asthma study
* no appropriate address for follow-up in the claims data.
D: Inclusion Criteria:

* Patients prescribed therapy equivalent to step 3 or higher on the Asthma Management Guidelines for at least 3 months
* At least one exacerbation in the previous year with systemic glucocorticoids
* Uncontrolled/Partially Controlled Asthma by GINA guidelines

Exclusion Criteria:

* Allergy to salmeterol/fluticasone
* Patients Controlled by GINA guidelines

Answer: A
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Effectiveness of a Resistance Training Program in the Workplace to Muscle Fatigue Control in Industrial Workers: Cluster Randomized Controlled Trial.
Brief Summary: Studies show that exercise resistance in workplace can reduce the symptoms of induced labor, however, the effectiveness of such programs depends on the characteristics of the training fatigue. Thus, it is expected that this study the intervention group with training heavy using progressive resistance exercise protocol will be better in reducing fatigue when compare with light training group.


Options:
A: Inclusion Criteria:

* sign informed consent

Exclusion Criteria:

* restriction by the medical department.
B: Inclusion Criteria:

* Must be a full-time employee on a fixed term contract for at least 18 months at one of the two worksites involved in the study (Macmillan Cancer Support, Public Health England)
* Must engage in primarily desk-based work
* Must have their own desk (i.e. does not hot desk) Must be primarily office based (i.e. not working from home)
* Must have no plans to leave the organisation for an extended period (e.g. holiday \> 4 weeks or secondment) or finitely before the anticipated study end date (January 2016)

Exclusion Criteria:

* Have engaged in standing-based desk work in the month prior to the start of the study
* Have been advised against standing by a health professional; or be unable to stand
* Work for the Macmillan Support Line
C: Inclusion Criteria:

* Constructions workers, working for more than 20 hours pr week, Physical heavy work tasks (in Danish: brolæggere, rørlæggere, mekanikere)

Exclusion Criteria:

* Workers with flexible job i.e. for people with a reduced ability to work
D: Inclusion Criteria:

* Employee at one of the hospital/clinic locations participating in the study

Exclusion Criteria:

* none

Answer: A
Please select the eligibility criteria that correspond to the clinical trial below.
Title: The Influence of Sit-stand Workstations Upon Total Physical Activity: a 12 Month Randomised Controlled Trial
Brief Summary: The purpose of this study is to examine the contribution of sit-stand workstations to total daily physical activity in a multi-component office-based 12 month intervention.


Options:
A: Inclusion Criteria:

* Must be a full-time employee on a fixed term contract for at least 18 months at one of the two worksites involved in the study (Macmillan Cancer Support, Public Health England)
* Must engage in primarily desk-based work
* Must have their own desk (i.e. does not hot desk) Must be primarily office based (i.e. not working from home)
* Must have no plans to leave the organisation for an extended period (e.g. holiday \> 4 weeks or secondment) or finitely before the anticipated study end date (January 2016)

Exclusion Criteria:

* Have engaged in standing-based desk work in the month prior to the start of the study
* Have been advised against standing by a health professional; or be unable to stand
* Work for the Macmillan Support Line
B: Inclusion Criteria:

* Participants were required to be sedentary, between 18-65 years old, have a BMI above 25.0 kg/m2 and physical inactive (not meeting the MVPA recommendations and not exceed 6000 steps/day). In addition subjects had to be free of any major disease with a general healthy status warranted.

Exclusion Criteria:

* Taking any medication or dietary supplements that may interfere with body composition or energy expenditure regulation, performing more than 5000 steps/day and meeting actual MVPA recommendations
C: Inclusion Criteria:

* Healthy Caucasian (no acute or chronic diseases)
* Normal weight or slightly overweight (BMI: 18.5 - 27.5 kg/m²)
* Regularly working in sedentary office environments
* Regular computer users
* Fluent German speakers
* Consented to participate

Exclusion Criteria:

* Heavily overweight \& Obesity (BMI \> 27.5 kg/m²)
* Short office stay duration (\< 8 h / day or \< 20 h / week)
* Experience in sit-to-stand workstations
* Acute or chronic diseases
* Inability to stand
* Visual impairments that had not been corrected
* Color blindness
* People planning to change their physical activity level
* Regular smokers (\> 1 cigarette /day)
* Not consented to participate
D: Inclusion Criteria:

* being employed

Exclusion Criteria:

* not being able to stand

Answer: A
Please select the eligibility criteria that correspond to the clinical trial below.
Title: The Influence of Sit-stand Workstations Upon Total Physical Activity: a 12 Month Randomised Controlled Trial
Brief Summary: The purpose of this study is to examine the contribution of sit-stand workstations to total daily physical activity in a multi-component office-based 12 month intervention.


Options:
A: Inclusion Criteria:

* Must be a full-time employee on a fixed term contract for at least 18 months at one of the two worksites involved in the study (Macmillan Cancer Support, Public Health England)
* Must engage in primarily desk-based work
* Must have their own desk (i.e. does not hot desk) Must be primarily office based (i.e. not working from home)
* Must have no plans to leave the organisation for an extended period (e.g. holiday \> 4 weeks or secondment) or finitely before the anticipated study end date (January 2016)

Exclusion Criteria:

* Have engaged in standing-based desk work in the month prior to the start of the study
* Have been advised against standing by a health professional; or be unable to stand
* Work for the Macmillan Support Line
B: Inclusion Criteria:

* Overweight and moderate obese patients (BMI: 25-34,9 kg/m2).
* Be 6 or more than 6 hours daily sitting.
* Able to walk and stand up from a chair unaided.
* Subjects who can guarantee a year continuity in the study.

Exclusion Criteria:

* Recommended contradictions to advising physical activity to overweight and obese people.
* Have an obesity surgical operation.
C: Inclusion Criteria:

* We will recruit overweight/obese (body mass index 25.0-40.0 kg/m2) adults (18-65 years) working in full-time (minimum 35 hours/week), sedentary (self-report sitting \>75% work time) occupations at an independent work site.

Exclusion Criteria:

* Working in an office that will not meet the space or electrical requirements of the active workstation, acute or chronic illness not under treatment of a provider, orthopedic limitations that prohibit physical activity, current or planned pregnancy, hospitalization from a physical or mental disorder in the past six months and/or taking medication that may impair physical activity
D: Inclusion Criteria:

* Participants were required to be sedentary, between 18-65 years old, have a BMI above 25.0 kg/m2 and physical inactive (not meeting the MVPA recommendations and not exceed 6000 steps/day). In addition subjects had to be free of any major disease with a general healthy status warranted.

Exclusion Criteria:

* Taking any medication or dietary supplements that may interfere with body composition or energy expenditure regulation, performing more than 5000 steps/day and meeting actual MVPA recommendations

Answer: A
Please select the eligibility criteria that correspond to the clinical trial below.
Title: The Influence of Sit-stand Workstations Upon Total Physical Activity: a 12 Month Randomised Controlled Trial
Brief Summary: The purpose of this study is to examine the contribution of sit-stand workstations to total daily physical activity in a multi-component office-based 12 month intervention.


Options:
A: Inclusion Criteria:

* those permanently assigned to one of the 45 IFD stations
* with a fire department-provided medical exam in the last two years
* at least 18 years of age
* full duty status at the time of consent

Exclusion Criteria:

* those without a recorded fire department exam in the last two years
* less than 18 years of age
* restrictions on duty at the time of consent.
B: Inclusion Criteria:

* Must be a full-time employee on a fixed term contract for at least 18 months at one of the two worksites involved in the study (Macmillan Cancer Support, Public Health England)
* Must engage in primarily desk-based work
* Must have their own desk (i.e. does not hot desk) Must be primarily office based (i.e. not working from home)
* Must have no plans to leave the organisation for an extended period (e.g. holiday \> 4 weeks or secondment) or finitely before the anticipated study end date (January 2016)

Exclusion Criteria:

* Have engaged in standing-based desk work in the month prior to the start of the study
* Have been advised against standing by a health professional; or be unable to stand
* Work for the Macmillan Support Line
C: Inclusion Criteria:

* MGH (benefited) employees who enroll in the Be Fit program
* Able to commit to 1 year of active research participation

Exclusion Criteria:

* Not enrolled in the Be Fit program
* Decline participation in the research study
* Withdrawal from the Be Fit 12 week program prior to completion
* Women who are currently pregnant or suspect they may be pregnant
* Plans to leave MGH within 3 months from enrolling in Be Fit
D: Inclusion Criteria:

* Corporate size equal to 100 to 999 part-time and full-time employees (excluding seasonal and temporary workers)
* Headquarters located in King County, Washington, and in a zip code within a 30 mile radius of the research center
* Within an industry with an average annual salary below the median annual salary for King County, Washington (defined by 3-digit NAICS code)
* 50% or more employees are age 35 or older

Exclusion Criteria:

* Do not offer health insurance to full-time employees
* In existence for less than 3 years
* No physical address to which employees report
* Current or previous participation in other workplace health promotion study
* Recent refuser or non-responder for other current workplace health promotion study
* Current participant in other American Cancer Society employer program
* Not willing to be randomized to intervention or comparison group

Answer: B
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Evaluation of a Patient-Centered Medication Therapy Management Intervention to Reduce Inappropriate Anticholinergic Prescribing in the Elderly
Brief Summary: This will be an eight-week, prospective, placebo-controlled, randomized trial to evaluate a patient-centered team (pharmacist-physician) intervention to improve medication appropriateness and reduce the use of inappropriate anticholinergic medications in elderly patients enrolled in the Sanders-Brown Alzheimer's Disease Center (ADC) cohort.


Options:
A: Inclusion Criteria:

* Enrolled at the Sander's Brown Center on Aging Alzheimer Disease Center
* Are 65 years of age or older
* Are taking at least one anticholinergic medication
* No cognitive impairment or mild cognitive impairment

Exclusion Criteria:

* Are younger than 65 years of age
* Have moderate to severe cognitive impairment
* Live in a long-term care facility
B: Inclusion Criteria:

* The subjects of this study will be physician providers and residents and medical students practicing under the supervision of a faculty emergency physician. Specific study subjects will include emergency medicine faculty physicians; emergency medicine and internal medicine residents; emergency medicine, surgery, and internal medicine interns; and medical students taking care of patients in our emergency department.

Exclusion Criteria:

* We will not include the members of the research team in this study.
C: Inclusion Criteria:

* 50 years and over
* 'At Risk' by having one or more of the following: a. Visits to emergency dept within the past 6 months; b. Admission to hospital for a medical problem in past 6 months; c. High service use profiles; d. Polypharmacy; e. Other high risk factors
* Capable of giving informed consent
* Able to use the Care Companion technology

Exclusion Criteria:

* Cognitive impairment such that they cannot give informed consent
* Unable or unwilling to use the telehomecare equipment
* Unlikely to tolerate the intensive intervention
* Language or cultural barriers
* Being acutely ill or having an unstable condition on entry to the study
D: Inclusion Criteria:

* The patient must be on the list of one of the family physicians participating in the study
* Home dwelling (not permanently institutionalised)
* Medications administered by the home nursing service
* Polypharmacy defined as the use of at least seven different systemic medications taken regularly
* Informed consent by the patient or a close relative

Exclusion Criteria:

* Patient or relative denies inclusion
* The family physician does not want the particular patient to participate
* Moderate/severe dementia (Clinical Dementia Rating Scale score \> 1) and contact with the closest proxy less than once every other week.
* The patient does not speak/understand Norwegian
* Expected to become permanently institutionalised within six months
* Life expectancy \< six months

Answer: A
Please select the eligibility criteria that correspond to the clinical trial below.
Title: Study on the Effectiveness of Occupational Therapy Intervention in Complex Patients.
Brief Summary: To date, there are no studies that demonstrate that the intervention of Occupational Therapy (OT) in patients considered to be complex, regardless of diagnosis, could improve clinical and functional outcome for the patient.

For this reason, we intend to undertake a study that will allow us to deepen the knowledge about the impact of the OT on in-hospital patients considered "complex" according to the assessment by the Rehabilitation Complexity Scale (RCS ).

Our hypothesis is that the intervention of OT can improve their care by qualified and focused on the needs of the person interventions.


Options:
A: Inclusion

* mild to moderate stroke
* traumatic brain-injury
* deficits in attention defined by the APT test
* lower average and above for reasoning skills
* lower average and above for abstract thinking
* good understanding of the Swedish language

Exclusion

* moderate to severe aphasia
* ongoing psychiatric illness
* history of severe somatic disorder causing anoxic periods
* ongoing substance abuse
* severe pain severe memory disorders,
* neglect
* visual field defects
* motor disability interfering with participation
B: Inclusion Criteria:

* to be over 18 years old,
* to have been diagnosed with stroke
* an occurrence of the injury of 12 month period ore more (chronic stage)
* cognitive impairment confirmed by pre-intervention neuropsychological assessment

Exclusion Criteria:

* diagnosis of language deficits or aphasia
* motor impairment concerning upper limbs that may incapacitate them for the use of the computer
* severe alteration of the visual field or perceptual problems
* health status that may require further intervention or admission to a medical center during the study;
* neurological or psychiatric history
* substance abuse.
C: Inclusion Criteria:

* 18 years old
* in charge of the rehabilitation ward of the hospital
* defined complexes as assessed by RCS
* consent to the processing of sensitive data for research purposes.

Exclusion Criteria:

* primary psychiatric conditions
* language barrier;
* cognitive impairment
* communicative disability
D: Inclusion Criteria:

* age between 18-90 years old
* hemisyndrome (central paralysis of the upper extremity, and all degrees of weakness: M0 - M5 on the paresis scale) as a result of a first stroke
* sub-acute lesion not more than 6 weeks post ictus

Exclusion Criteria:

* insufficient state of consciousness
* severe aphasia
* severe cognitive deficits
* severe pathologies of the upper extremity of traumatic or rheumatic nature
* severe pain in the affected arm
* Patients with pacemakers and other active implants

Answer: C